Skoči na glavni sadržaj

Izvorni znanstveni članak

COMPARISION OF COSTS OF SECONDARY PREVENTION AND TREATMENT OF STROKE – COST-EFFECTIVENESS ANALYSIS

Ivana Ceronja
Zvonko Šošić


Puni tekst: hrvatski pdf 151 Kb

preuzimanja: 435

citiraj


Sažetak

Cerebrovascular accident (CVA) is a serious complication of untreated arterial hypertension. Introduction: The aim of this paper is to compare the cost of secondary prevention and treatment of CVA caused by untreated arterial hypertension. Methods: Cost-effectiveness analysis of diagnosis and therapy of arterial hypertension in comparison with CVA treatment. Results: The cost of secondary prevention of CVA per patient per year in 2006. was 1.589,19 kunas, which comes to 15.107,75 kunas in thirty years of treatment (discount factor included), whereas a single CVA treatment was 17.207,54 kunas on average. In every 850 treatments of hypertension (NNT) comes a prevented CVA which is 1.350.811,5 kunas, and is therefore more expensive than a single CVA treatment. Conclusion: Secondary prevention has a long-term protective effect improving the patients’ quality of life, inhibiting the potential post-CVA handicap and pre-retirement. Thus, the main advantage of both primary and secondary prevention is in their greater benefit for patients.

Ključne riječi

Hypertension – economics, diagnosis, therapy, complications; Stroke – economics, etiology, therapy, prevention and control; Cost-benefit analysis

Hrčak ID:

171846

URI

https://hrcak.srce.hr/171846

Datum izdavanja:

31.10.2011.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.605 *